Microbiome–Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers
Cancer Science · 2026
DOI: 10.1111/cas.70448 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancer Science, 2026. Verfasst von Atsunari Kawashima und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Graduate School of Medicine, The University of Osaka, Osaka, Japan. Hauptthemen laut MEDLINE: Urogenital Neoplasms, Carcinoma, Renal Cell, Carcinogenesis, Kidney Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
The microbiome is increasingly recognized as a regulator of carcinogenesis, tumor immunity, and response to immune checkpoint inhibitors (ICIs), but its role in genitourinary cancers remains less clearly defined than in melanoma or colorectal cancer. In this review, we summarize evidence that microbiome‐related pathways influence urothelial carcinoma (UC) and renal cell carcinoma (RCC) across the continuum from tumor initiation to immunotherapy outcome. We highlight recent preclinical studies showing that gut microbial environments can causally modify urothelial carcinogenesis through carcinogen metabolism, inflammatory priming, and diet‐microbiome interactions in N‐butyl‐N‐(4‐hydroxybutyl) nitrosamine‐based mouse models, including a newly established upper tract urothelial carcinoma mouse model, as well as emerging clinical data indicating that circulating extracellular vesicle (EV)‐associated bacterial DNA is associated with tumor immune phenotypes and ICI outcomes in UC and RCC. Because blood is a low‐biomass matrix, we use the term “circulating microbial signals” rather than “blood microbiome” and emphasize the need for contamination‐aware analysis, careful EV characterization, and external validation. Current evidence supports a framework in which microbiome‐related signals connect intestinal ecology, systemic immune tone, tumor immune contexture, and treatment response, while indicating that circulating EV‐associated bacterial DNA remains an exploratory biomarker platform.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Urology, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
- Laboratory of Molecular and Cellular Physiology, Graduate School of Pharmaceutical Sciences, The University of Osaka, Osaka, Japan.
- Department of Surgery, Graduate School of Medicine, The University of Osaka, Osaka, Japan.
ORCID-Profile: Atsunari Kawashima, Kentaro Jingushi, Takuro Saito, Akinaru Yamamoto, Norio Nonomura
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Kawashima, A., Jingushi, K., Saito, T., Uemura, T., Yamamoto, A., Sassi, N., Horitani, H., Inoguchi, S., Horibe, Y., Ishizuya, Y., Hayashi, T., Yamamoto, Y., & Nonomura, N. (2026). Microbiome–Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers. Cancer Science. https://doi.org/10.1111/cas.70448
Vancouver
Kawashima A, Jingushi K, Saito T, Uemura T, Yamamoto A, Sassi N, et al. Microbiome–Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers. Cancer Science. 2026. doi:10.1111/cas.70448
BibTeX
@article{Kawashima2026,
author = {Kawashima, Atsunari and Jingushi, Kentaro and Saito, Takuro and Uemura, Toshihiro and Yamamoto, Akinaru and Sassi, Nesrine and Horitani, Hiromu and Inoguchi, Shunsuke and Horibe, Yuki and Ishizuya, Yu and Hayashi, Takuji and Yamamoto, Yoshiyuki and Nonomura, Norio},
title = {Microbiome–Driven Carcinogenesis and Circulating Microbial Signals in Genitourinary Cancers},
journal = {Cancer Science},
year = {2026},
doi = {10.1111/cas.70448}
}
EUVIMED